Seagen Inc.
Anti-NTB-A antibodies and related compositions and methods

Last updated:

Abstract:

Disclosed are antibodies, including antibody drug conjugates, that specifically bind to NTB-A. Also disclosed are methods for using the anti-NTB-A antibodies to detect or modulate activity of (e.g., inhibit proliferation of) an NTB-A-expressing cell, as well as for diagnoses or treatment of diseases or disorders (e.g., cancer) associated with NTB-A-expressing cells, such as multiple myeloma, non-Hodgkin lymphoma and acute myeloid leukemia.

Status:
Grant
Type:

Utility

Filling date:

30 Jun 2016

Issue date:

7 Jun 2022